Approval · Notice of Compliance 1737 · 2001
ONCOTICE BCG: Notice of Compliance 1737
Issued February 16, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1737
- Date
- February 16, 2001
- Company
- N.V. Organon
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antineoplastic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ONCOTICE BCG | 02153513 | Marketed |
Medicinal ingredients
- BACILLUS CALMETTE-GUERIN (BCG) STRAIN TICE 800,000,000 UNIT per VIAL